# Nextech Invest Ltd.: Form 13F holdings

An institutional investment manager in Zurich. SEC CIK 1595430.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $2.11bn
- Positions: 15 (16 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1595430/000159543026000010/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $1.42bn | 67.6% | 7,601,087 |  | Unchanged |
| [PARABILIS MEDICINES INC (PBLS)](/companies/pbls.md) | COM | $127.6m | 6.1% | 4,663,176 |  | New +4,663,176 |
| [RELAY THERAPEUTICS INC (RLAY)](/companies/rlay.md) | COM | $126.8m | 6.0% | 6,776,506 |  | Added +1,250,000 |
| [TYRA BIOSCIENCES INC (TYRA)](/companies/tyra.md) | COM | $113.5m | 5.4% | 3,553,585 |  | Reduced −502,276 |
| [ALUMIS INC (ALMS)](/companies/alms.md) | COM | $99.6m | 4.7% | 3,540,998 |  | Unchanged |
| [ORIC PHARMACEUTICALS INC (ORIC)](/companies/oric.md) | COM | $77.6m | 3.7% | 7,162,637 |  | Unchanged |
| [KYMERA THERAPEUTICS INC (KYMR)](/companies/kymr.md) | COM | $32.0m | 1.5% | 278,896 |  | Unchanged |
| [ZYMEWORKS INC (ZYME)](/companies/zyme.md) | COM | $29.1m | 1.4% | 1,113,946 |  | Unchanged |
| [MONTE ROSA THERAPEUTICS INC (GLUE)](/companies/glue.md) | COM | $18.4m | 0.9% | 761,153 |  | Added +456,916 |
| [ARVINAS INC (ARVN)](/companies/arvn.md) | COM | $17.1m | 0.8% | 1,122,713 |  | Added +583,319 |
| [CYTOMX THERAPEUTICS INC. (CTMX)](/companies/ctmx.md) | COM | $16.7m | 0.8% | 4,449,932 |  | Unchanged |
| [SILENCE THERAPEUTICS PLC (SLN)](/companies/sln.md) | ADS | $10.5m | 0.5% | 952,400 |  | Unchanged |
| [CORVUS PHARMACEUTICALS INC (CRVS)](/companies/crvs.md) | COM | $6.7m | 0.3% | 450,000 |  | Unchanged |
| [CONTEXT THERAPEUTICS INC (CNTX)](/companies/cntx.md) | COM | $4.1m | 0.2% | 7,419,355 |  | Unchanged |
| [ENGENE THERAPEUTICS INC (ENGN)](/companies/engn.md) | COM | $4.0m | 0.2% | 2,324,943 |  | New +2,324,943 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ARS PHARMACEUTICALS INC (SPRY)](/companies/spry.md) | COM | $0 | 0.0% | 0 |  | Sold out −610,703 |
| [CULLINAN THERAPEUTICS INC (CGEM)](/companies/cgem.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,141,145 |
| ENGENE HOLDINGS INC | COM | $0 | 0.0% | 0 |  | Sold out −2,324,943 |
| [TANGO THERAPEUTICS INC (TNGX)](/companies/tngx.md) | COM | $0 | 0.0% | 0 |  | Sold out −7,266,081 |

Source: SEC EDGAR, Form 13F-HR, accession 0001595430-26-000010. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.